[ Price : $8.95]
Novartis says interim clinical data show that its MF59-adjuvanted vaccine was well tolerated and could potentially quadruple the N...[ Price : $8.95]
FDA asks the Pulmonary-Allergy Drugs Advisory Committee whether clinical trial data support a claim that Pfizer/Boehringer Ingelhe...[ Price : $8.95]
Federal Register Final rule: FDA approves a Pharmacia & Upjohn NADA for using progesterone inserts for induction of estrus in ewes...[ Price : $8.95]
Federal Register Notice: FDA plans a meeting of the General and Plastic Surgery Devices Panel 3/25/10 to discuss recent informatio...[ Price : $8.95]
Federal Register Notice: FDAs National Mammography Quality Assurance Advisory Committee will meet 1/25/10 to discuss recent guidan...[ Price : $8.95]
Federal Register Notice: FDAs Oncologic Drugs Advisory Committee will meet 12/16 to discuss GlaxoSmithKlines supplemental NDA for ...[ Price : $8.95]
Federal Register Notice: FDA plans a public workshop 1/11-12/10 on the thermal aspects of radio frequency exposure.[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Abbott Molecular, Arnold Tuber, Dynamic Nutritional, Anthony Dallas, and Eisai.